Fraxinus Americana Pollen - NDC Database
8 records found
Page:
0268-1021 Jan 01, 1965
Fraxinus Americana Pollen .001 g/ml Subcutaneous Injection, Solution by Alk-abello, Inc.
Fraxinus Americana Pollen .001 g/ml Subcutaneous Injection, Solution by Alk-abello, Inc.
0268-1022 Jan 01, 1965
Fraxinus Americana Pollen .1 g/ml Subcutaneous Injection, Solution by Alk-abello, Inc.
Fraxinus Americana Pollen .1 g/ml Subcutaneous Injection, Solution by Alk-abello, Inc.
0268-1023 Jan 01, 1965
Fraxinus Americana Pollen .05 g/ml Subcutaneous Injection, Solution by Alk-abello, Inc.
Fraxinus Americana Pollen .05 g/ml Subcutaneous Injection, Solution by Alk-abello, Inc.
0268-1024 Jan 01, 1965
Fraxinus Americana Pollen 40000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
Fraxinus Americana Pollen 40000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
0268-1025 Jan 01, 1965
Fraxinus Americana Pollen 10000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
Fraxinus Americana Pollen 10000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
0268-1026 Jan 01, 1965
Fraxinus Americana Pollen 20000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
Fraxinus Americana Pollen 20000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
0268-6603 Jan 01, 1965
Fraxinus Americana Pollen .05 g/ml Percutaneous Injection, Solution by Alk-abello, Inc.
Fraxinus Americana Pollen .05 g/ml Percutaneous Injection, Solution by Alk-abello, Inc.
0268-6680 Jan 01, 1965
Fraxinus Americana Pollen 1000 [pnu]/Ml Intradermal Injection, Solution by Alk-abello, Inc.
Fraxinus Americana Pollen 1000 [pnu]/Ml Intradermal Injection, Solution by Alk-abello, Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.